UNSW scientists have grown human pancreatic cancer tumors in the lab—their model is the first of its kind, with important future clinical implications.
Jan 22, 2021
0
33
A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn't live any longer than expected after receiving pre-operative chemotherapy from either of the two standard regimens, according ...
Jan 21, 2021
0
7
A protein found commonly in human blood might help with the detection of hard-to-diagnose pancreatic tumors. Researchers at Martin Luther University Halle-Wittenberg (MLU), the Alfried Krupp Hospital in Essen and the University ...
Jan 21, 2021
0
4
Researchers at Rush University Medical Center have found that opioid use might increase a person's risk of developing pancreatic cancer.
Jan 06, 2021
0
64
A DNA mutation that occurs frequently in the development of many pancreatic tumors appears to make these cancers vulnerable to an existing type of drug known as PARP inhibitors, according to a new study from scientists in ...
Dec 15, 2020
0
1437
The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine—an herb used in China ...
Dec 14, 2020
0
11
According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated ...
Dec 09, 2020
0
3
The UK's national tissue bank for pancreatic diseases is open for applications from any UK-based researchers needing samples of blood, urine and saliva to aid their research.
Dec 09, 2020
0
1
Researchers say they've identified a way to disrupt a process that promotes the growth of pancreatic cancers—one of the most difficult and deadly cancers to treat.
Dec 08, 2020
0
28
Prostate cancer is the second-most diagnosed cancer in men after skin cancer. Approximately 1 of 9 men in the U.S. will get prostate cancer in his lifetime. Most men diagnosed with the disease won't die from it. More than ...
Nov 19, 2020
0
5
Pancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still extremely rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas. Exocrine pancreatic cancers are far more common than endocrine pancreatic cancers (islet cell carcinomas), which make up about 1% of total cases.
This text uses material from Wikipedia, licensed under CC BY-SA
